Condensed Consolidated Balance Sheets - USD ($)
|
Aug. 31, 2019 |
Feb. 28, 2019 |
| Current assets |
|
|
| Cash and cash equivalents |
$ 37,931,040
|
$ 5,833,390
|
| Sales tax, tax credits and other receivables (Note 3) |
716,314
|
599,000
|
| Prepaid expenses |
248,712
|
226,521
|
| Total current assets |
38,896,066
|
6,658,911
|
| Investment in joint venture (Note 8) |
500,000
|
0
|
| Property, plant and equipment, net (Note 4) |
6,428,004
|
5,371,263
|
| Intangible assets, net (Note 5) |
200,351
|
127,672
|
| Total assets |
46,024,421
|
12,157,846
|
| Current liabilities |
|
|
| Accounts payable and accrued liabilities (Notes 7) |
1,511,976
|
2,670,233
|
| Convertible notes (Notes 6 and 10) |
4,259,759
|
5,636,172
|
| Warrants (Note 10) |
0
|
219,531
|
| Current portion of long-term debt (Notes 6 and 9) |
52,651
|
53,155
|
| Total current liabilities |
5,824,386
|
8,579,091
|
| Long-term debt (Notes 6 and 9) |
917,012
|
952,363
|
| Total liabilities |
6,741,398
|
9,531,454
|
| Stockholders' Equity |
|
|
| Series A Preferred stock par value $0.0001; 25,000,000 shares authorized; one share issued and outstanding (Note 11) |
0
|
0
|
| Common stock par value $0.0001: 250,000,000 shares authorized; 34,875, 032 shares issued and outstanding (February 28, 2019 - 33, 805,706) |
3,903
|
3,381
|
| Additional paid-in capital |
74,414,197
|
38,966,208
|
| Additional paid-in capital - Warrants (Notes 10 and 11) |
9,700,102
|
757,704
|
| Additional paid-in capital - Beneficial conversion feature (Note 10) |
1,200,915
|
1,200,915
|
| Common stock issuable, 1,000,000 shares (Note 11) |
0
|
800,000
|
| Accumulated deficit |
(45,708,185)
|
(38,811,592)
|
| Accumulated other comprehensive loss |
(327,909)
|
(290,224)
|
| Total stockholders' equity |
39,283,023
|
2,626,392
|
| Total liabilities and stockholders' equity |
$ 46,024,421
|
$ 12,157,846
|